Review
doi: 10.1038/nrd1202.
Target discovery
Affiliations
- PMID: 14526386
- DOI: 10.1038/nrd1202
Item in Clipboard
Review
Target discovery
Nat Rev Drug Discov.
2003 Oct.
Abstract
Target discovery, which involves the identification and early validation of disease-modifying targets, is an essential first step in the drug discovery pipeline. Indeed, the drive to determine protein function has been stimulated, both in industry and academia, by the completion of the human genome project. In this article, we critically examine the strategies and methodologies used for both the identification and validation of disease-relevant proteins. In particular, we will examine the likely impact of recent technological advances, including genomics, proteomics, small interfering RNA and mouse knockout models, and conclude by speculating on future trends.
Similar articles
-
Fulfilling the promise: drug discovery in the post-genomic era.Drug Discov Today. 2003 Feb 15;8(4):168-74. doi: 10.1016/s1359-6446(02)02595-3. Drug Discov Today. 2003. PMID: 12581711 Review.
-
Target validation and drug discovery using genomic and protein-protein interaction technologies.Expert Opin Ther Targets. 2002 Aug;6(4):517-31. doi: 10.1517/14728222.6.4.517. Expert Opin Ther Targets. 2002. PMID: 12223066 Review.
-
Towards high-throughput characterization of small molecule mechanisms of action.Mol Biosyst. 2006 Dec;2(12):609-20. doi: 10.1039/b609384a. Epub 2006 Oct 27. Mol Biosyst. 2006. PMID: 17216042 Review.
-
The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.Toxicol Lett. 2009 Apr 10;186(1):45-51. doi: 10.1016/j.toxlet.2008.10.014. Epub 2008 Oct 28. Toxicol Lett. 2009. PMID: 19022361
-
Main approaches to target discovery and validation.Methods Mol Biol. 2007;360:1-12. doi: 10.1385/1-59745-165-7:1. Methods Mol Biol. 2007. PMID: 17172722 Review.
Cited by
-
Genome-wide RNAi screen in IFN-γ-treated human macrophages identifies genes mediating resistance to the intracellular pathogen Francisella tularensis.PLoS One. 2012;7(2):e31752. doi: 10.1371/journal.pone.0031752. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359626 Free PMC article.
-
Screening phage display libraries for organ-specific vascular immunotargeting in vivo.Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):407-12. doi: 10.1073/pnas.0506938103. Epub 2005 Dec 29. Proc Natl Acad Sci U S A. 2006. PMID: 16384919 Free PMC article.
-
Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.Anal Biochem. 2007 Mar 1;362(1):44-54. doi: 10.1016/j.ab.2006.12.023. Epub 2006 Dec 20. Anal Biochem. 2007. PMID: 17241609 Free PMC article.
-
Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.Mol Cell Biol. 2008 Aug;28(15):4896-914. doi: 10.1128/MCB.01775-07. Epub 2008 May 27. Mol Cell Biol. 2008. PMID: 18505826 Free PMC article.
-
The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective.PLoS One. 2016 Nov 9;11(11):e0165737. doi: 10.1371/journal.pone.0165737. eCollection 2016. PLoS One. 2016. PMID: 27828998 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
